Compensative shuttling of merlin to phosphorylation on serine 518 in vestibular schwannoma

Laryngoscope

Volumn 118, Issue 1, 2008, Pages 169-174

  Lü, Jingrong ^a   Zou, Jing ^a,b   Wu, Hao ^a,c   Cai, Lihui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cyclin D1; Immunohistochemistry; Merlin; Phosphorylation; Tumor suppressor; Vestibular schwannoma

Indexed keywords

CYCLIN D1; MERLIN; SERINE;

ARTICLE; CELL CYCLE REGULATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEURILEMOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VESTIBULAR NERVE; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; BIOLOGICAL TRANSPORT, ACTIVE; CELL CYCLE; CELL NUCLEUS; CYCLIN D1; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSCOPY, CONFOCAL; NEUROFIBROMIN 2; NEUROMA, ACOUSTIC; PHOSPHORYLATION; S PHASE; SERINE;

EID: 37549004744     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e3181566594     Document Type: Article

References (29)

1. Yoshimoto Y. Systematic review of the natural history of vestibular schwannoma. J Neurosurg 2005;103:59-63.
2. Gronholm M, Teesalu T, Tyynela J, et al. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system. Mol Cell Neurosci 2005;28:683-693.
3. McClatchey AI. Merlin and ERM proteins: unappreciated roles in cancer development? Nat Rev Cancer 2003;3:877-883.
4. Zwarthoff EC. Neurofibromatosis and associated tumour suppressor genes. Pathol Res Pract 1996;192:647-657.
5. Bai Y, Liu YJ, Wang H, Xu Y, Stamenkovic I, Yu Q. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Oncogene 2007;26:836-850.
6. Bashour AM, Meng JJ, Ip W, MacCollin M, Ratner N. The neurofibromatosis type 2 gene product, merlin, reverses the F-actin cytoskeletal defects in primary human schwannoma cells. Mol Cell Biol 2002;22:1150-1157.
7. Manchanda N, Lyubimova A, Ho HY, et al. The NF2 tumor suppressor Merlin and the ERM proteins interact with N-WASP and regulate its actin polymerization function. J Biol Chem 2005;280:12517-12522.
8. Rangwala R, Banine F, Borg JP, Sherman LS. Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells. J Biol Chem 2005;280:11790-11797.
9. Poulikakos PI, Xiao GH, Gallagher R, Jablonski S, Jhanwar SC, Testa JR. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK. Oncogene 2006;25:5960-5968.
10. Schulze KM, Hanemann CO, Muller HW, Hanenberg H. Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis. Hum Mol Genet 2002;11:69-76.
11. Muranen T, Gronholm M, Renkema GH, Carpen O. Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin. Oncogene 2005;24:1150-1158.
12. Rong R, Surace EI, Haipek CA, Gutmann DH, Ye K. Serine 518 phosphorylation modulates merlin intramolecular association and binding to critical effectors important for NF2 growth suppression. Oncogene 2004;23:8447-8454.
13. Nishio J, Althof PA, Bailey JM, et al. Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma. Lab Invest 2006;86:547-556.
14. Stemmer-Rachamimov AO, Gonzalez-Agosti C, Xu L, et al. Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system. J Neuropathol Exp Neurol 1997;56:735-742.
15. Stemmer-Rachamimov AO, Xu L, Gonzalez-Agosti C, et al. Universal absence of merlin, but not other ERM family members, in schwannomas. Am J Pathol 1997;151:1649-1654.
16. den Bakker MA, Vissers KJ, Molijn AC, Kros JM, Zwarthoff EC, van der Kwast TH. Expression of the neurofibromatosis type 2 gene in human tissues. J Histochem Cytochem 1999;47:1471-1480.
17. Ajchenbaum F, Ando K, DeCaprio JA, Griffin JD. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J Biol Chem 1993;268:4113-4119.
18. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 1993;7:812-821.
19. Kissil JL, Johnson KC, Eckman MS, Jacks T. Merlin phosphorylation by p21-activated kinase 2 and effects of phosphorylation on merlin localization. J Biol Chem 2002;277:10394-10399.
20. Shaw RJ, Paez JG, Curto M, et al. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell 2001;1:63-72.
21. Xiao GH, Beeser A, Chernoff J, Testa JR. p21-activated kinase links Rac/Cdc42 signaling to merlin. J Biol Chem 2002;277:883-886.
22. den Bakker MA, Riegman PH, Hekman RA, et al. The product of the NF2 tumour suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells. Oncogene 1995;10:757-763.
23. den Bakker MA, Tascilar M, Riegman PH, et al. Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am J Pathol 1995;147:1339-1349.
24. Huynh DP, Mautner V, Baser ME, Stavrou D, Pulst SM. Immunohistochemical detection of schwannoma and neurofibromin in vestibular schwannomas, ependymomas and meningiomas. J Neuropathol Exp Neurol 1997;56:382-390.
25. Bian LG, Tirakotai W, Sun QF, Zhao WG, Shen JK, Luo QZ. Molecular genetics alterations and tumor behavior of sporadic vestibular schwannoma from the People's Republic of China. J Neurooncol 2005;73:253-260.
26. Morrison H, Sherman LS, Legg J, et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001;15:968-980.
27. Bai Y, Liu YJ, Wang H, Xu Y, Stamenkovic I, Yu Q. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Oncogene 2007;26:836-850.
28. Utermark T, Schubert SJ, Hanemann CO. Rearrangements of the intermediate filament GFAP in primary human schwannoma cells. Neurobiol Dis 2005;19:1-9.
29. Surace EI, Haipek CA, Gutmann DH. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function. Oncogene 2004;23:580-587.